Chylomicrons combined with endotoxin moderate microvascular permeability

Innate Immunity

Volumn 17, Issue 3, 2011, Pages 283-292

  Spitzer, Austin L ^a,b   Chuang, Kelley I ^a,b   Victorino, Gregory P ^b   Kasravi, Behzad ^a   Curran, Brian ^b   Lee, Diana ^a   Harris, Hobart W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

chylomicron; endothelium; hydraulic conductivity; platelet activating factor; tumor necorosis factor

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CHYLOMICRON; ENDOTOXIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SYNAPTOTAGMIN I; THROMBOCYTE ACTIVATING FACTOR; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; VASCULAR ENDOTHELIAL CADHERIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL ADHESION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; HUMAN; HUMAN CELL; HYDRAULIC CONDUCTIVITY; INNATE IMMUNITY; MICROVASCULATURE; NONHUMAN; RAT;

ANIMALS; ANTIGENS, CD; CADHERINS; CAPILLARY PERMEABILITY; CELL ADHESION; CELL MEMBRANE PERMEABILITY; CELLS, CULTURED; CHYLOMICRONS; EIF-2 KINASE; ENDOTHELIAL CELLS; ENDOTOXINS; GRAM-NEGATIVE BACTERIA; IMMUNITY, INNATE; IMMUNOSUPPRESSION; NF-KAPPA B; RATS; RATS, SPRAGUE-DAWLEY; SEPSIS; TUMOR NECROSIS FACTOR-ALPHA;

NEGIBACTERIA; RATTUS;

EID: 79958797942     PISSN: 17534259     EISSN: 17534267     Source Type: Journal    
DOI: 10.1177/1753425910369849     Document Type: Article

References (42)

1. Barcia AM, Harris HW Triglyceride-rich lipoproteins as agents of innate immunity. Clin Infect Dis 2005 ; 41 (Suppl 7). S498 - S503.
2. Harris HW, Rockey DC, Chau P. Chylomicrons alter the hepatic distribution and cellular response to endotoxin in rats. Hepatology 1998 ; 27: 1341-1348. (Pubitemid 28227862)
3. Kumwenda ZL, Wong CB, Johnson JA, Gosnell JE, Welch WJ, Harris HW Chylomicron-bound endotoxin selectively inhibits NF-kappaB activation in rat hepatocytes. Shock 2002 ; 18: 182-188.
4. Harris HW, Grunfeld C., Feingold KR, Rapp JH Human very low density lipoproteins and chylomicrons can protect against endotoxin-induced death in mice. J Clin Invest 1990 ; 86: 696-702. (Pubitemid 20327356)
5. Harris HW, Grunfeld C., Feingold KR et al. Chylomicrons alter the fate of endotoxin, decreasing tumor necrosis factor release and preventing death. J Clin Invest 1993 ; 91: 1028-1034. (Pubitemid 23095278)
6. Kasravi FB, Welch WJ, Peters-Lideu CA, Weisgraber KH, Harris HW Induction of cytokine tolerance in rodent hepatocytes by chylomicron-bound LPS is low-density lipoprotein receptor dependent. Shock 2003 ; 19: 157-162.
7. Kasravi FB, Lee DH, Weisgraber K., Harris HW Lipoprotein-bound endotoxin exerts an immunomodulatory effect on hepatocytes through the lipid A domain of LPS. J Endotoxin Res 2005 ; 11: 19-24. (Pubitemid 40533075)
8. Bernard GR, Vincent JL, Laterre PF et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001 ; 344: 699-709. (Pubitemid 32204987)
9. Ferro T., Neumann P., Gertzberg N., Clements R., Johnson A. Protein kinase C-alpha mediates endothelial barrier dysfunction induced by TNF-alpha. Am J Physiol 2000 ; 278: L1107 - L1117.
10. Ferro TJ, Gertzberg N., Selden L., Neumann P., Johnson A. Endothelial barrier dysfunction and p42 oxidation induced by TNF-alpha are mediated by nitric oxide. Am J Physiol 1997 ; 272: L979 - L988.
11. Goldblum SE, Ding X., Campbell-Washington J. TNF-alpha induces endothelial cell F-actin depolymerization, new actin synthesis, and barrier dysfunction. Am J Physiol 1993 ; 264: C894 - C905.
12. Johnson J., Meyrick B., Jesmok G., Brigham KL Human recombinant tumor necrosis factor alpha infusion mimics endotoxemia in awake sheep. J Appl Physiol 1989 ; 66: 1448-1454. (Pubitemid 19091383)
13. Anderson BO, Bensard DD, Harken AH The role of platelet activating factor and its antagonists in shock, sepsis and multiple organ failure. Surg Gynecol Obstet 1991 ; 172: 415-424.
14. Kubes P., Suzuki M., Granger DN Modulation of PAF-induced leukocyte adherence and increased microvascular permeability. Am J Physiol 1990 ; 259: G859 - G864.
15. Victorino GP, Newton CR, Curran B. Modulation of microvascular hydraulic permeability by platelet-activating factor. J Trauma 2004 ; 56: 379-384. (Pubitemid 38295384)
16. Baldwin Jr AS The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol 1996 ; 14: 649-683. (Pubitemid 26130197)
17. Siebenlist U., Franzoso G., Brown K. Structure, regulation and function of NF-kappa B. Annu Rev Cell Biol 1994 ; 10: 405-455.
18. Han SJ, Choi JH, Ko HM et al. Glucocorticoids prevent NFkappaB activation by inhibiting the early release of platelet-activating factor in response to lipopolysaccharide. Eur J Immunol 1999 ; 29: 1334-1341. (Pubitemid 29164180)
19. Han SJ, Ko HM, Choi JH et al. Molecular mechanisms for lipopolysaccharide-induced biphasic activation of nuclear factor-kappa B (NF-kappa B). J Biol Chem 2002 ; 277: 44715-44721.
20. Martins IJ, Vilcheze C., Mortimer BC, Bittman R., Redgrave TG Sterol side chain length and structure affect the clearance of chylomicron-like lipid emulsions in rats and mice. J Lipid Res 1998 ; 39: 302-312. (Pubitemid 28100668)
21. Redgrave TG, Maranhao RC Metabolism of protein-free lipid emulsion models of chylomicrons in rats. Biochim Biophys Acta 1985 ; 835: 104-112. (Pubitemid 15019654)
22. Morrow JA, Arnold KS, Weisgraber KH Functional characterization of apolipoprotein E isoforms overexpressed in Escherichia coli. Protein Expr Purif 1999 ; 16: 224-230. (Pubitemid 29342124)
23. Curry FE, Sarelius IH Techniques in Life Sciences. New York: Elsevier, 1983 ; 1-34.
24. Kendall S., Michel CC The measurement of permeability in single rat venules using the red cell microperfusion technique. Exp Physiol 1995 ; 80: 359-372.
25. Victorino GP, Newton CR, Curran B. The effect of tonicity and hypertonic solutions on microvascular permeability. J Surg Res 2002 ; 104: 101-105. (Pubitemid 34948518)
26. Victorino GP, Newton CR, Curran B. Effect of angiotensin II on microvascular permeability. J Surg Res 2002 ; 104: 77-81. (Pubitemid 34948514)
27. Zeng M., Zhang H., Lowell C., He P. Tumor necrosis factor-alpha-induced leukocyte adhesion and microvessel permeability. Am J Physiol 2002 ; 283: H2420 - H2430.
28. Skinner RA, Tucker VL, Curry FR Acute effects of tumor necrosis factor on hydraulic conductivity of mammalian post-capillary venules. J Trauma 1999 ; 47: 486-491. (Pubitemid 29444385)
29. Nwariaku FE, Liu Z., Zhu X., Turnage RH, Sarosi GA, Terada LS Tyrosine phosphorylation of vascular endothelial cadherin and the regulation of microvascular permeability. Surgery 2002 ; 132: 180-185. (Pubitemid 35024759)
30. He P., Zhang H., Zhu L., Jiang Y., Zhou X. Leukocyte-platelet aggregate adhesion and vascular permeability in intact micro-vessels: role of activated endothelial cells. Am J Physiol 2006 ; 291: H591 - H599.
31. Lee YM, Hybertson BM, Cho HG, Repine JE Platelet-activating factor induces lung inflammation and leak in rats: hydrogen peroxide production along neutrophil-lung endothelial cell interfaces. J Lab Clin Med 2002 ; 140: 312-319. (Pubitemid 35302023)
32. Matsuda N., Hattori Y., Jesmin S., Gando S. Nuclear factor-kappaB decoy oligodeoxynucleotides prevent acute lung injury in mice with cecal ligation and puncture-induced sepsis. Mol Pharmacol 2005 ; 67: 1018-1025. (Pubitemid 40410404)
33. Sarada S., Himadri P., Mishra C., Geetali P., Ram MS, Ilavazhagan G. Role of oxidative stress and NF-κB in hypoxia-induced pulmonary edema. Exp Biol Med (Maywood) 2008 ; 233: 1088-1098.
34. Jones E., Adcock IM, Ahmed BY, Punchard NA Modulation of LPS stimulated NF-kappaB mediated nitric oxide production by PKCepsilon and JAK2 in RAW macrophages. J Inflamm (Lond) 2007 ; 4: 23.
35. Kim YM, Lee BS, Yi KY, Paik SG Upstream NF-kappaB site is required for the maximal expression of mouse inducible nitric oxide synthase gene in interferon-gamma plus lipopolysaccharide-induced RAW 264.7 macrophages. Biochem Biophys Res Commun 1997 ; 236: 655-660.
36. Morrison DC, Silverstein R., Luchi M., Shnyra A. Structure-function relationships of bacterial endotoxins. Contribution to microbial sepsis. Infect Dis Clin North Am 1999 ; 13: 313-340. (Pubitemid 29248747)
37. Seydel U., Oikawa M., Fukase K., Kusumoto S., Brandenburg K. Intrinsic conformation of lipid A is responsible for agonistic and antagonistic activity. Eur J Biochem 2000 ; 267: 3032-3039. (Pubitemid 30321351)
38. Persing DH, Coler RN, Lacy MJ et al. Taking toll: lipid A mimetics as adjuvants and immunomodulators. Trends Microbiol 2002 ; 10: S32 - S37.
39. Nwariaku FE, Liu Z., Zhu X. et al. NADPH oxidase mediates vascular endothelial cadherin phosphorylation and endothelial dysfunction. Blood 2004 ; 104: 3214-3220. (Pubitemid 39507137)
40. Hudry-Clergeon H., Stengel D., Ninio E., Vilgrain I. Platelet-activating factor increases VE-cadherin tyrosine phosphorylation in mouse endothelial cells and its association with the PtdIns3'kinase. FASEB J 2005 ; 19: 512-520. (Pubitemid 40471242)
41. Harris HW, Gosnell JE, Kumwenda ZL The lipemia of sepsis: triglyceride-rich lipoproteins as agents of innate immunity. J Endotoxin Res 2000 ; 6: 421-430. (Pubitemid 32409428)
42. Kasravi FB, Brecht WJ, Weisgraber KH, Harris HW Induction of cytokine tolerance requires internalization of chylomicron-bound LPS into hepatocytes. J Surg Res 2003 ; 115: 303-309. (Pubitemid 38021922)